The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy
<p>Telomerase is expressed in the majority (>85%) of tumours but not in differentiated normal tissue. This enzyme catalyses the elongation of telomeres – a process critical for continued cell proliferation. Telomerase is a potential novel target for molecularly-targeted radiotherapy (mR...
1. autor: | Jackson, M |
---|---|
Kolejni autorzy: | Vallis, K |
Format: | Praca dyplomowa |
Język: | English |
Wydane: |
2013
|
Hasła przedmiotowe: |
Podobne zapisy
-
Selective targeting of homologous recombination deficiency
od: Zimmer, J
Wydane: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
od: Albukhari, A
Wydane: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
od: Albukhari, A
Wydane: (2014) -
Development of models and methods to assess the efficacy of anti-cancer drugs targeted to the mitochondria
od: Potter, M
Wydane: (2014) -
Radiopharmaceutical Validation for Clinical Use
od: Charles A. Kunos, i wsp.
Wydane: (2021-03-01)